Canagliflozin (CANA) Reduces Serum Uric Acid (SUA) in Patients with Type 2 Diabetes Mellitus (T2DM)

被引：0

|

作者：

Davies, Michael

Trujillo, Angelina

Vijapurkar, Ujjwala

Damara-Ju, C. V.

Meininger, Gary

机构：

来源：

DIABETES | 2014年 / 63卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1090-P

引用

收藏

页码：A283 / A284

页数：2

相关论文

共 50 条

[1] Blood Pressure (BP) Effects of Canagliflozin (CANA) in Patients with Type 2 Diabetes Mellitus (T2DM)
Pfeifer, Michael
Townsend, Raymond
Davies, Michael J.
Vijapurkar, Ujjwala
Ren, Jimmy
DIABETES, 2016, 65 : A303 - A303
[2] Genital Mycotic Infections With Canagliflozin (CANA) in Subjects With Type 2 Diabetes Mellitus (T2DM)
Nyirjesy, Paul
Sobel, Jack
Fung, Albert
Gassmann-Mayer, Cristiana
Ways, Kirk
Usiskin, Keith
DIABETES, 2013, 62 : A276 - A276
[3] Achievement of Diabetes-related Treatment Goals with Canagliflozin (CANA) in Patients with Type 2 Diabetes Mellitus (T2DM)
Blonde, Lawrence
Woo, Vincent
Mathieu, Chantal
Yee, Jacqueline
Vijapurkar, Ujjwala
Meininger, Gary
DIABETES, 2014, 63 : A284 - A284
[4] Effect of Canagliflozin (CANA) on Liver Function Tests (LFTs) in Patients with Type 2 Diabetes Mellitus (T2DM)
Usiskin, Keith
Leiter, Lawrence A.
Forst, Thomas
Polidori, David
Xie, John
Sha, Sue
DIABETES, 2014, 63 : A284 - A284
[5] Pharmacokinetics (PK) and Pharmacodynamics (PD) of Canagliflozin (CANA) in Pediatric Patients with Type 2 Diabetes Mellitus (T2DM)
Tamborlane, William
Polidori, David
Di Prospero, Nicolas
DIABETES, 2017, 66 : A371 - A371
[6] Consistent Effects of Canagliflozin (CANA) Across Racial Subgroups of Patients with Type 2 Diabetes Mellitus (T2DM)
Gavin, James R., III
Davies, Melanie J.
Davies, Michael
Vija-Purkar, Ujjwala
Alba, Maria
DIABETES, 2014, 63 : A285 - A285
[7] Urinary Tract Infection (UTI) With Canagliflozin (CANA) in Subjects With Type 2 Diabetes Mellitus (T2DM)
Nicolle, Lindsay E.
Capuano, George
Fung, Albert
Usiskin, Keith
DIABETES, 2013, 62 : A296 - A296
[8] Lower Blood Pressure (BP) With Canagliflozin (CANA) in Subjects With Type 2 Diabetes Mellitus (T2DM)
Weir, Matthew R.
Januszewicz, Andrzej
Gilbert, Richard
Gonzalez, Fernando Lavalle
Meininger, Gary
DIABETES, 2013, 62 : A278 - A278
[9] Effects of Canagliflozin (CANA) on Biomarkers of Cardiovascular (CV) Stress in Older Patients with Type 2 Diabetes Mellitus (T2DM)
Januzzi, James L.
Butler, Javed
Jarolim, Petr
Sattar, Naveed
Vijapurkar, Ujjwala
Merton, Katherine W.
Ren, Jimmy
Canovatchel, William
Desai, Mehul
Davies, Michael J.
DIABETES, 2017, 66 : LB40 - LB40
[10] Effect of canagliflozin on serum uric acid in patients with type 2 diabetes mellitus
Davies, M. J.
Trujillo, A.
Vijapurkar, U.
Damaraju, C. V.
Meininger, G.
DIABETES OBESITY & METABOLISM, 2015, 17 (04): : 426 - 429

← 1 2 3 4 5 →